Newton Investment Management (BNY) argues that US equity outperformance is normalizing rather than ending, with Europe taking the lead early in 2025, and maintains an overweight in European-listed companies with global exposure. The piece outlines sector views across consumer, industrials, AI/tech, and healthcare, while noting select opportunities arising from tariff-driven market dislocations.